Cresco Labs Inc. (OTCMKTS:CRLBF) Receives Consensus Rating of "Buy" from Brokerages

Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report) has earned an average recommendation of "Buy" from the five ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, one has issued a buy rating and two have given a strong buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is $3.00.

A number of equities research analysts have recently weighed in on CRLBF shares. Cormark raised Cresco Labs from a "hold" rating to a "moderate buy" rating in a research note on Monday, March 17th. Atb Cap Markets downgraded shares of Cresco Labs from a "strong-buy" rating to a "hold" rating in a research note on Monday, December 9th.

Cresco Labs Price Performance

OTCMKTS CRLBF traded up $0.01 during trading hours on Friday, reaching $0.74. 488,260 shares of the stock traded hands, compared to its average volume of 607,410. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.97 and a quick ratio of 1.39. The stock has a 50 day simple moving average of $0.86 and a two-hundred day simple moving average of $1.15. Cresco Labs has a 1 year low of $0.69 and a 1 year high of $2.60. The company has a market cap of $361.22 million, a price-to-earnings ratio of -3.70 and a beta of 1.79.

Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last announced its quarterly earnings data on Friday, March 14th. The company reported ($0.01) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.01). The company had revenue of $176.00 million for the quarter, compared to analysts' expectations of $172.10 million. Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%. On average, analysts predict that Cresco Labs will post -0.2 EPS for the current fiscal year.

Remove Ads

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.